Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Could Overt Diabetes Be Triggered by Abuse of Selective Androgen Receptor Modulators and Growth Hormone Secretagogues? A Case Report and Review of the Literature.

Literature DB >> 35983415

Could Overt Diabetes Be Triggered by Abuse of Selective Androgen Receptor Modulators and Growth Hormone Secretagogues? A Case Report and Review of the Literature.

Richard Sotorník^1,2, Roguel Suissa¹, Jean-Luc Ardilouze³.

Abstract

Entities: Chemical

Year: 2022 PMID： 35983415 PMCID： PMC9331610 DOI： 10.2337/cd21-0044

Source DB: PubMed Journal: Clin Diabetes ISSN： 0891-8929

Keyword Cloud
References

× No keyword cloud information.

46 in total

Review 1. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors: Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal: Endocr Rev Date: 2013-12-17 Impact factor: 19.871

2. Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140.

Authors: Chris P Miller; Maysoun Shomali; C Richard Lyttle; Louis St L O'Dea; Hillary Herendeen; Kyla Gallacher; Dottie Paquin; Dennis R Compton; Bishwabhusan Sahoo; Sean A Kerrigan; Matthew S Burge; Michael Nickels; Jennifer L Green; John A Katzenellenbogen; Alexei Tchesnokov; Gary Hattersley
Journal: ACS Med Chem Lett Date: 2010-12-02 Impact factor: 4.345

3. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

Authors: James T Dalton; Kester G Barnette; Casey E Bohl; Michael L Hancock; Domingo Rodriguez; Shontelle T Dodson; Ronald A Morton; Mitchell S Steiner
Journal: J Cachexia Sarcopenia Muscle Date: 2011-08-02 Impact factor: 12.910

4. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.

Authors: E Codner; F Cassorla; A N Tiulpakov; M V Mericq; A Avila; O H Pescovitz; J Svensson; K Cerchio; D Krupa; B J Gertz; G Murphy
Journal: Clin Pharmacol Ther Date: 2001-07 Impact factor: 6.875

5. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents.

Authors: Katsuya Dezaki; Hiroshi Hosoda; Masafumi Kakei; Suzuko Hashiguchi; Masatomo Watanabe; Kenji Kangawa; Toshihiko Yada
Journal: Diabetes Date: 2004-12 Impact factor: 9.461

6. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.

Authors: Ralf Nass; Suzan S Pezzoli; Mary Clancy Oliveri; James T Patrie; Frank E Harrell; Jody L Clasey; Steven B Heymsfield; Mark A Bach; Mary Lee Vance; Michael O Thorner
Journal: Ann Intern Med Date: 2008-11-04 Impact factor: 25.391